BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
FXYD4
,
calcium channel activity
,
Allergy to pollen
,
Pancreas
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neurofibromatosis type 2
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
NF2
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Ezrin/radixin/moesin, C-terminal
Ezrin/radixin/moesin
Moesin tail domain superfamily
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22
Ezrin/radixin/moesin-like
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Congenital disorder
Explore Curated Studies Results
Literature
Most Relevant Literature
Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' t…
Prediction and evaluation of deleterious and disease causing non-synonymous SNPs (nsSNPs) in human N…
NF2 Gene Participates in Regulation of the Cell Cycle of Meningiomas by Restoring Spindle Assembly C…
Neurofibromatosis type 2 in Phelan-McDermid syndrome: Institutional experience and review of the lit…
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mous…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Natural History Study of Patients With Neurofibromatosis Type 2
PTC299 for Treatment of Neurofibromatosis Type 2
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progr…
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ